Dr Annelize Koch and Dr Simon Hutchings review the revised EMA FiH guidance effective February 2018, and suggest how these guidelines can be used effectively to accelerate your early clinical development.
Who We Are
Our Services
Clinical Trial Management Services
Central Laboratory Services
Clinical Pharmacology
Scintigraphy
Pharmacovigilance
Regulatory Affairs
Clinical & Medical Writing
Data Quality, Security & Compliance
Clinical Trial Management Services
Phase I
Phase II
Phase III
Site Management & Monitoring
IMP Management
Biometric Services
Dr Annelize Koch and Dr Simon Hutchings review the revised EMA FiH guidance effective February 2018, and suggest how these guidelines can be used effectively to accelerate your early clinical development.